Cargando…
Diagnostic value of aberrant decreased 5-Methylcytosine RNA modification in leukocytes for non-small cell lung cancer
Background: Non-small cell lung cancer (NSCLC) was a disease with poor outcomes, partly because there were no high-efficiency non-invasive diagnostic biomarkers. The RNA modification status of 5-Methylcytosine (m(5)C) has been shown to be a biomarker for various diseases, but its potentiality to be...
Autores principales: | Huang, Mao, Ming, Liang, Jiang, Hongbo, Jiang, Ping, Jiang, Xi, Yin, Haofan, Hong, Honghai |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Ivyspring International Publisher
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10414042/ https://www.ncbi.nlm.nih.gov/pubmed/37576401 http://dx.doi.org/10.7150/jca.85681 |
Ejemplares similares
-
5-Methylcytosine (m(5)C) modification in peripheral blood immune cells is a novel non-invasive biomarker for colorectal cancer diagnosis
por: Yin, Haofan, et al.
Publicado: (2022) -
5-methylcytosine modification of an Epstein–Barr virus noncoding RNA decreases its stability
por: Henry, Belle A., et al.
Publicado: (2020) -
Elevated N6-Methyladenosine RNA Levels in Peripheral Blood Immune Cells: A Novel Predictive Biomarker and Therapeutic Target for Colorectal Cancer
por: Xie, Jinye, et al.
Publicado: (2021) -
Role of main RNA modifications in cancer: N(6)-methyladenosine, 5-methylcytosine, and pseudouridine
por: Xue, Chen, et al.
Publicado: (2022) -
5-methylcytosine modification by Plasmodium NSUN2 stabilizes mRNA and mediates the development of gametocytes
por: Liu, Meng, et al.
Publicado: (2022)